Scienture Holdings, Inc. (FRA:4E4)

Market Cap	20.99M
Revenue (ttm)	556.89K
Net Income (ttm)	-17.52M
Shares Out	n/a
EPS (ttm)	-1.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.3620
Previous Close	0.3620
Day's Range	0.3620 - 0.3620
52-Week Range	0.2880 - 3.6400
Beta	n/a
RSI	43.59
Earnings Date	Nov 19, 2025

About Scienture Holdings

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potas...

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Employees: 19
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4E4

Financial Performance

Financial numbers in USD